ENHERTU® Granted Breakthrough Therapy Designation in U.S. for Patients with HER2 Low Metastatic Breast Cancer
Based on DESTINY-Breast04 results where Daiichi Sankyo and AstraZeneca’s ENHERTU demonstrated significant improvement in both…
Based on DESTINY-Breast04 results where Daiichi Sankyo and AstraZeneca’s ENHERTU demonstrated significant improvement in both…
SINGAPORE--(BUSINESS WIRE)--Thoughtworks (NASDAQ: TWKS), a global technology consultancy that integrates strategy, design and engineering to…
The new partnership with Dettol Pro Solutions provides the same trusted Dettol products to Accor…
Industry leader and OneStream partner brings deep domain expertise and extensive implementation experience to the…
As per UserTesting’s survey, 85% of respondents feel lunchflation is a serious concern as food…
Revenue and earnings above the mid-point of Q1 guidance Revenue of $755 million in Q1’22,…
Clients will benefit from enhanced service and future digital self-service CHRISTCHURCH, New Zealand--(BUSINESS WIRE)--#Cloud--FINEOS Corporation…
CHAMPAIGN, Ill., April 26, 2022 (GLOBE NEWSWIRE) -- First Busey Corporation (Nasdaq: BUSE) Message from…
WESTFIELD, Mass., April 26, 2022 (GLOBE NEWSWIRE) -- Western New England Bancorp, Inc. (the “Company”…
Bi-weekly, 18-day trip is fastest ocean freight service from Vietnam to US CLEVELAND--(BUSINESS WIRE)--UWL, a…